Accessibility Tools

Low-grade Gliomas

What are Low-grade Gliomas?

Low-grade gliomas (LGGs) are slow-growing primary brain tumours that arise from glial cells, which provide structural and functional support to the nervous system. These tumours are typically classified as World Health Organisation (WHO) Grade 2 and are more commonly diagnosed in younger adults compared to high-grade malignant brain tumours. Although low-grade gliomas tend to grow more slowly, they can still significantly impact neurological function and may progress to more aggressive forms over time.

Types of Low-grade Gliomas

The 2 main subtypes of Low Grade Glioma are:

  • Astrocytomas
  • Oligodendrogliomas

Symptoms of Low-grade Gliomas

The common symptoms of low-grade gliomas vary depending on tumour size, growth rate, and location within the brain.

Neurological Symptoms:

  • Persistent headaches
  • Seizures (often the first presenting symptom)
  • Cognitive or behavioural changes
  • Memory difficulties
  • Speech disturbances
  • Motor weakness or coordination problems
  • Visual disturbances

General Symptoms:

  • Nausea or vomiting
  • Fatigue
  • Increased intracranial pressure in advanced cases

Risk Factors of Low-grade Gliomas

Although exact causes are not always clear, contributing factors may include:

  • Genetic predisposition
  • Prior radiation exposure
  • Certain hereditary syndromes
  • Family history of brain tumours

Diagnosis of Low-grade Gliomas

Diagnosis of low-grade gliomas involves detailed neurological and radiological assessment including:

  • MRI brain with contrast (gold standard)
  • Biopsy for histopathological confirmation
  • Molecular testing (e.g., IDH mutation, 1p/19q codeletion)

Treatment of Low-grade Gliomas

Management of low-grade gliomas depends on tumour type, size, location, and the patient’s health status.

  • Surgical resection: Preferred initial treatment when feasible
  • Active surveillance: In select cases of slow-growing, asymptomatic tumour
  • Targeted therapy: Vorasidenib (IDH inhibitor)
  • Radiation therapy: For residual or progressive disease
  • Chemotherapy: Commonly temozolomide or PCV regimen is recommended

Prognosis of Low-grade Gliomas

Low-grade gliomas generally have a better prognosis than high-grade gliomas, but outcomes vary based on molecular profile, age, and extent of the tumour and surgical removal. Long-term follow-up is essential, as recurrence or malignant transformation can occur.

Chris O’Brien Lifehouse, Sydney

Level 4, Suite 19,
Chris O'Brien Lifehouse,
119-143 Missenden Road,
Camperdown 2050

Get directions
  • Royal Prince Alfred Hospital, Sydney Logo
  • Chris O’Brien Lifehouse, Sydney Logo
  • The University of Sydney Logo
  • Neurosurgical Society of Australasia Logo
  • Melanoma Institute Australia Logo
  • Australian Medical Association Logo